Balance Wealth’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$557K Sell
8,571
-6,979
-45% -$316K 0.13% 87
2026
Q2
$443K Buy
+15,550
New +$339K 0.12% 100
2025
Q2
– Sell
-10,666
Closed -$189K – 104
2025
Q1
$189K Buy
+10,666
New +$230K 0.12% 108

Other funds holding CDNA

Balance Wealth's CDNA Position: Q3 2026 in Review

Balance Wealth reduced its CareDx (CDNA) stake by 45% in Q3 2026, selling an estimated $316K and leaving 8,571 shares worth $557K. The position accounts for 0.13% of the portfolio, ranked #87.

Balance Wealth first reported a position in CDNA in Q1 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Balance Wealth held 8,571 shares of CareDx worth $557K as of Q3 2026.
  • Balance Wealth sold 6,979 CareDx shares in Q3 2026, an estimated $316K.
  • CareDx made up 0.13% of Balance Wealth's portfolio in Q3 2026, its #87 holding.
  • Balance Wealth first reported a position in CareDx in Q1 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.